L, G., C, A., G, D., A, S., F, Z., A, C., . . . G, L. M. (2022). Safety of Intradialytic Bamlanivimab/Etesevimab Administration in Two COVID-19 Dialysis Outpatients. Blood purification, 51(10), 875. https://doi.org/10.1159/000521637
Chicago Style (17th ed.) CitationL, Gasperoni, Abenavoli C, Donati G, Scrivo A, Zappulo F, Cingolani A, Hu L, and La Manna G. "Safety of Intradialytic Bamlanivimab/Etesevimab Administration in Two COVID-19 Dialysis Outpatients." Blood Purification 51, no. 10 (2022): 875. https://doi.org/10.1159/000521637.
MLA (9th ed.) CitationL, Gasperoni, et al. "Safety of Intradialytic Bamlanivimab/Etesevimab Administration in Two COVID-19 Dialysis Outpatients." Blood Purification, vol. 51, no. 10, 2022, p. 875, https://doi.org/10.1159/000521637.